Faculty profile

Matthew Mcqueen

Back to faculty

Professor EmeritusPathology & Molecular MedicineMcMaster University

Matthew Mcqueen

Professor Emeritus

Pathology & Molecular Medicine

Faculty of Health Sciences

McMaster University

Hamilton, Ontario, Canada

In this role since 2014

Supervision signals

Emeritus professors are retired and rarely take new students.
No graduate courses on record.
8 publications in the last five years, latest in 2025.
Principal investigator on 1 CIHR grant, most recently in 2009.

These signals come from public records; CIHR grant records currently run to 2022. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

264

Publications

44,377

Citations

h-index

137

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Academic profiles

University Profile Search on Google Scholar OpenAlex

Social profiles

𝕏Search on X inSearch on LinkedIn 🦋Search on Bluesky ▶Search on YouTube

Contact

mcqueen@mcmaster.ca (905) 522-1155 ext. 3841

Research

Research areas, by share of publications

Acute Myocardial Infarction ResearchMedicine
Diabetes, Cardiovascular Risks, and LipoproteinsMedicine
Lipoproteins and Cardiovascular HealthMedicine
Chronic Kidney Disease and DiabetesMedicine
Clinical Laboratory Practices and Quality ControlMedicine

Research areas are derived from OpenAlex topics of their publications.

From the 150 most recent of 264 publications.

Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE) A Prospective Cohort Study

Joseph P, Avezum Á, Ramasundarahettige C, Mony PK, Yusuf R, Kazmi K, Szuba A, Lopez-Jaramillo P, Diaz ML, Yusufali AH

Journal of the American College of Cardiology202534 citations

DOI: 10.1016/j.jacc.2024.10.121

Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case–control study

Wang X, Liu X, O'Donnell MJ, McQueen M, Sniderman A, Pare G, Hankey GJ, Rangarajan S, Chin SL, Rao-Melacini P

EClinicalMedicine202432 citationsOpen Access

DOI: 10.1016/j.eclinm.2024.102515 PMID: W4392827660

Determinants of serious health outcome‐free status in middle‐aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial

Mohammedi K, Hess S, McQueen M, Pigeyre M, Lee SF, Pare G, Gerstein HC

Diabetes, Obesity and Metabolism2024

DOI: 10.1111/dom.15654

The Clinical Validation of a Common Analytical Change Criteria for Cardiac Troponin for Ruling in an Acute Cardiovascular Outcome in Patients Presenting with Ischemic Chest Pain Symptoms

Kavsak PA, Sharif S, Globe I, Ainsworth C, Ma J, McQueen M, Mehta S, Ko DT, Worster A

Journal of Cardiovascular Development and Disease20238 citationsOpen Access

DOI: 10.3390/jcdd10080335 PMID: W4385576187

High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality

Devereaux PJ, Lamy A, Zheng H, Parlow JL, Underwood MJ, Wang CY, Choi S, Fremes S, Urrútia G, Maestre M

New England Journal of Medicine2022166 citations

DOI: 10.1056/nejmoa2000803

Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial.

Mehta SR, Pare G, Lonn EM, Jolly SS, Natarajan MK, Pinilla-Echeverri N, Schwalm J-D, Sheth TN, Sibbald M, Tsang M

EuroIntervention202277 citations

DOI: 10.4244/eij-d-22-00735

Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)

O’Donnell MJ, McQueen M, Sniderman A, Pare G, Wang X, Hankey GJ, Rangarajan S, Chin SL, Rao-Melacini P, Ferguson J

Journal of Stroke202240 citationsOpen Access

DOI: 10.5853/jos.2021.02152 PMID: W4282023851

Biomarkers of Prevalent and Incident Cognitive Dysfunction in People with Dysglycemia: Data from the ORIGIN Trial

Cukierman-Yaffe T, Lee S-F, Pare G, McQueen M, Hess S, Gerstein HC

Journal of Alzheimer's Disease20221 citations

DOI: 10.3233/jad-215195

Diagnostic Performance of Serial High-Sensitivity Cardiac Troponin Measurements in the Emergency Setting

Kavsak PA, Hewitt MK, Mondoux SE, Cerasuolo JO, Ma J, Clayton N, McQueen M, Griffith LE, Perez R, Seow H

Journal of Cardiovascular Development and Disease202112 citationsOpen Access

DOI: 10.3390/jcdd8080097 PMID: W3193719623

NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia – A brief report from the ORIGIN trial

Wijkman MO, Claggett BL, Pfeffer MA, Paré G, McQueen M, Hess S, Lee SF, Gerstein HC

Journal of Diabetes and its Complications20215 citations

DOI: 10.1016/j.jdiacomp.2021.107928

Researchers with similar interests

Joseph Macri

Pathology & Molecular Medicine

Diabetes, Cardiovascular Risks, and Lipoproteins, Lipoproteins and Cardiovascular Health

Adnan Hameed

Medicine

Acute Myocardial Infarction Research, Diabetes, Cardiovascular Risks, and Lipoproteins

Peter Kavsak

Pathology & Molecular Medicine

Acute Myocardial Infarction Research, Clinical Laboratory Practices and Quality Control

Eva Lonn

Medicine

Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins

Bernardo Trigatti

Biochemistry & Biomedical Sciences

Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins

Shamir Mehta

Medicine

Acute Myocardial Infarction Research

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Acute Myocardial Infarction Research Dear Professor Mcqueen, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE) A Prospective Cohort Study" (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Open in email

Something wrong or missing on this profile? Suggest a correction

Matthew Mcqueen

Research

Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE) A Prospective Cohort Study

Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case–control study

Determinants of serious health outcome‐free status in middle‐aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial

The Clinical Validation of a Common Analytical Change Criteria for Cardiac Troponin for Ruling in an Acute Cardiovascular Outcome in Patients Presenting with Ischemic Chest Pain Symptoms

High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality

Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial.

Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)

Biomarkers of Prevalent and Incident Cognitive Dysfunction in People with Dysglycemia: Data from the ORIGIN Trial

Diagnostic Performance of Serial High-Sensitivity Cardiac Troponin Measurements in the Emergency Setting

NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia – A brief report from the ORIGIN trial

Frequent collaborators

Salim Yusuf

Hertzel Gerstein

Koon Teo

Eva Lonn

Peter Kavsak

Sonia Anand

Researchers with similar interests

Joseph Macri

Adnan Hameed

Peter Kavsak

Eva Lonn

Bernardo Trigatti

Shamir Mehta